Cannabichromene

1. 2026-10-19issueIssued emergency
2. 2026-10-19issueIssued info_card
3. 2026-09-07srcAnticancer effect of minor phytocannabinoids in preclinical models of multiple myeloma
4. 2026-09-07srcEvaluation of Cytochrome P450-Mediated Cannabinoid-Drug Interactions in Healthy Adult Participants
5. 2026-09-07srcBiological activity of cannabichromene, its homologs and isomers
6. 2026-09-07srcCannabichromene, a key non-psychotropic phytocannabinoid in treatment of major depressive disorder: in silico and in vivo explorations
7. 2026-09-07srcPharmacokinetic studies and synergistic antitumor effects of cannabichromene and cannabidiol in drug-resistant breast cancers
8. 2026-09-07srcEffect of cannabichromene on hepatic microsomal enzyme activity in the mouse
9. 2026-09-07srcChemical diversity, receptor binding affinity, and pharmacology of phytocannabinoids: Insights into neuronal mechanisms.
10. 2026-09-07srcImpact of minor cannabinoids on key pharmacological targets of estrogen receptor-positive breast cancer.
11. 2026-09-07srcDesign and synthesis of amphiphilic cannabichromene derivatives with antimicrobial potential
12. 2026-09-07srcDesign, synthesis, and biological evaluation of membrane-active cannabichromene derivatives as potent antibacterial agents
13. 2026-09-07srcCannabichromene from full-spectrum hemp extract exerts acute anti-seizure effects through allosteric activation of GABAA receptors.
14. 2026-09-07srcAntiepileptic activity and potential mechanism of full-spectrum hemp extract.
15. 2026-09-07srcDifferences in receptor binding affinity of several phytocannabinoids do not explain their effects on neural cell cultures.
16. 2026-09-07srcPhytocannabinoids biosynthesis during early stages of development of young Cannabis sativa L. seedlings
17. 2026-09-07srcEvaluation of cannabimimetic effects of selected minor cannabinoids and Terpenoids in mice.
18. 2026-09-07srcHepatic biotransformation of non-psychotropic phytocannabinoids and activity screening on cytochromes P450 and UDP-glucuronosyltransferases.
19. 2026-09-07srcNatural Cannabichromene (CBC) Shows Distinct Scalemicity Grades and Enantiomeric Dominance in Cannabis sativa Strains
20. 2026-09-07srcAn Unexpected Activity of a Minor Cannabinoid: Cannabicyclol (CBL) Is a Potent Positive Allosteric Modulator of Serotonin 5-HT1A Receptor
21. 2026-09-07srcEffect of Quantitative Structural Properties and Drug Formulation in Four Cannabinoids on Their Lymphatic Transport after Enteral Administration in Rats
22. 2026-09-07srcAntibacterial cannabinoids from Cannabis sativa: a structure-activity study.
23. 2026-09-07srcCannabichromene, a new active principle in hashish
24. 2026-09-07srcPhytocannabinoids: a unified critical inventory
25. 2026-09-07srcEvaluation of the Modulatory Effects of Minor Cannabinoids and Terpenes on Delta-9-Tetrahydrocannabinol Discrimination in Rats
26. 2026-09-07srcThe anti-biofilm activity of cannabinoids against methicillin-resistant Staphylococcus aureus.
27. 2026-09-07srcBroad-spectrum bactericidal synergy of silver-cannabichromene-cannabigerol triple combinations against healthcare-associated pathogens
28. 2026-09-07srcThe Mechanism of Cannabichromene and Cannabidiol Alone Versus in Combination in the Alleviation of Arthritis-Related Inflammation
29. 2026-09-07srcDifferential effectiveness of selected non-psychotropic phytocannabinoids on human sebocyte functions implicates their introduction in dry/seborrhoeic skin and acne treatment
30. 2026-09-07srcNon-psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action
31. 2026-09-07srcEffects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes
32. 2026-09-07srcTaming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects
33. 2026-09-07srcInhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice
34. 2026-09-07srcEntourage effects of nonpsychotropic cannabinoids on visceral sensitivity in experimental colitis
35. 2026-09-07srcDirect antigonadal activity of cannabinoids: suppression of rat granulosa cell functions
36. 2026-09-07srcA potential role for cannabichromene in modulating TRP channels during acute respiratory distress syndrome
37. 2026-09-07srcAnti-inflammatory and analgesic potential of minor cannabinoids in vivo
38. 2026-09-07srcRecent advances in Cannabis sativa research: biosynthetic studies and its potential in biotechnology
39. 2026-09-07srcCannabigerol and cannabichromene in Cannabis sativa L.
40. 2026-09-07srcEffects of cannabinoids on macromolecular synthesis and replication of cultured lymphocytes
41. 2026-09-07srcCannabinoids as Antibacterial Agents: A Systematic and Critical Review of In Vitro Efficacy Against Streptococcus and Staphylococcus
42. 2026-09-07srcExploring the Potential of Synthetic Cannabinoids: Modulation of Biological Activity of Normal and Cancerous Human Colon Epithelial Cells
43. 2026-09-07srcEffects of Rare Phytocannabinoids on the Endocannabinoid System of Human Keratinocytes
44. 2026-09-07srcRare Phytocannabinoids Exert Anti-Inflammatory Effects on Human Keratinocytes via the Endocannabinoid System and MAPK Signaling Pathway
45. 2026-09-07srcEvaluating the Antitumor Potential of Cannabichromene, Cannabigerol, and Related Compounds from Cannabis sativa and Piper nigrum Against Malignant Glioma
46. 2026-09-07srcSynergistic Anticancer Activity of Cannabinoids and Terpenes Against Triple-Negative Breast Cancer Resistance
47. 2026-09-07srcIdentification and Characterization of Cannabichromene's Major Metabolite Following Incubation with Human Liver Microsomes
48. 2026-09-07srcCannabichromene CBC legal status - hemp-derived cannabinoids under 2018 Farm Bill
49. 2026-09-04issueIssued emergency
50. 2026-09-04issueIssued info_card
51. 2026-09-04issueIssued notice
52. 2026-06-04proposal21 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
53. 2026-06-04publicationPublication — backfill
54. 2026-05-11revisionRevision 1
55. 2026-05-11genGeneration — pipeline-v5 · with 6 morepipeline-v5
56. 2026-05-11rungeneration run

The same entries, as forms: six forms.